{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:22:51Z","timestamp":1758709371562},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4-5","license":[{"start":{"date-parts":[[1991,11,1]],"date-time":"1991-11-01T00:00:00Z","timestamp":688953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[1991,11]]},"DOI":"10.1007\/bf00332555","type":"journal-article","created":{"date-parts":[[2004,10,29]],"date-time":"2004-10-29T16:13:11Z","timestamp":1099066391000},"page":"163-168","source":"Crossref","is-referenced-by-count":8,"title":["The effects of thromboxane receptor blockade on platelet aggregation and digital skin blood flow in patients with secondary Raynaud's syndrome"],"prefix":"10.1007","volume":"11","author":[{"given":"C. S.","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J. F.","family":"Belch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0002-9610(81)90272-5","volume":"142","author":"JM Porter","year":"1981","unstructured":"Porter JM, Rivers SP, Anderson CJ, Baur GM (1981) Evaluation and management of patients with Raynaud's syndrome. Am J Surg 142:183?189","journal-title":"Am J Surg"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bmj.291.6500.921","volume":"291","author":"W Taylor","year":"1985","unstructured":"Taylor W (1985) Vibration white finger: a newly proscribed disease. BMJ 291:921","journal-title":"BMJ"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1056\/NEJM198304143081507","volume":"308","author":"RJ Rodeheffer","year":"1983","unstructured":"Rodeheffer RJ, Rommer JA, Wigley F, Smith CR (1983) Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 308:880?883","journal-title":"N Engl J Med"},{"key":"CR4","first-page":"293","volume":"30","author":"S Moncada","year":"1979","unstructured":"Moncada S, Vane JR (1979) Pharmacology and endogenous roles of prostaglandins endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 30:293?331","journal-title":"Pharmacol Rev"},{"key":"CR5","first-page":"313","volume":"I","author":"JJF Belch","year":"1981","unstructured":"Belch JJF, Newman P, Drury JK et al (1981) Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. Lancet I:313?315","journal-title":"Lancet"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2125.1983.tb02119.x","volume":"15","author":"JJF Belch","year":"1983","unstructured":"Belch JJF, Cormie J, Newman P et al (1983) Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double blind trial. Br J Clin Pharmacol 15:113?116","journal-title":"Br J Clin Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1109\/TBME.1980.326686","volume":"27","author":"GE Nilsson","year":"1980","unstructured":"Nilsson GE, Tenland T, Oberg PA (1980) A new instrument for continuous measurement of tissue blood flow by light beating specroscopy. IEEE. Trans Biochem Engin 27:12?19","journal-title":"IEEE. Trans Biochem Engin"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/rheumatology\/24.4.346","volume":"24","author":"JJF Belch","year":"1985","unstructured":"Belch JJF, O'Dowd A, Forbes CD, Sturrock RD (1985) Platelet sensitivity to a prostacyclin analogue in systemic sclerosis. Br J Rheumatol 24:346?250","journal-title":"Br J Rheumatol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/1523-1747.ep12461206","volume":"89","author":"MH Rustin","year":"1987","unstructured":"Rustin MH, Bull HA, Machin SJ et al (1987) Serum from patients with Raynaud's phenomenon inhibits prostacyclin production. J Invest Dermatol 89:555?559","journal-title":"J Invest Dermatol"},{"key":"CR10","first-page":"3","volume":"4","author":"JY Jeremy","year":"1988","unstructured":"Jeremy JY, Mikhailidis DP, Hutton RA, Dandona P (1988) The effect of cooling on in vitro vascular prostacyclin and platelet thromboxane A2 synthesis: relevance to cold induced pathology. Microcirc Endothilium Lymphatics 4:3?20","journal-title":"Microcirc Endothilium Lymphatics"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/pgmj.63.742.617","volume":"63","author":"M Rademaker","year":"1987","unstructured":"Rademaker M, Thomas RH, Provost G et al (1987) Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis. Postgrad Med J 63:617?620","journal-title":"Postgrad Med J"},{"issue":"6","key":"CR12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0049-3848(82)90311-5","volume":"26","author":"G Defreyn","year":"1982","unstructured":"Defreyn G, Deckmyn H, Vermylen J (1982) A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2. Thromb Res 26 (6):389?400","journal-title":"Thromb Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2362.1985.tb00138.x","volume":"15","author":"H Tindall","year":"1985","unstructured":"Tindall H, Tooke JE, Menys VC et al. (1985) Effects of dazoxiben, a thromboxane synthetase inhibitor on skin blood flow following cold challenge in patients with Raynaud's phenomenon. Eur J Clin Invest 15:20?23","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 2","key":"CR14","first-page":"15","volume":"28","author":"CS Lau","year":"1989","unstructured":"Lau CS, McLaren M, Chopra M, Belch JJF (1989) Vibration induced white finger syndrome: a true secondary Raynaud's syndrome? Br J Rheumatol [Suppl 2] 28:15","journal-title":"Br J Rheumatol"},{"key":"CR15","first-page":"18","volume-title":"The assessment and associated problems of vibration white finger (VWF)","author":"JJF Belch","year":"1989","unstructured":"Belch JJF, McLaren M, Chopra M, O'Dowd A, Forbes CD (1989) Coagulation and haemorrheological abnormalities in patients with vibration white fingers. In: Aw TC, Cooke RA, Harrington JM, Krishnan G, Tyler LE (eds) The assessment and associated problems of vibration white finger (VWF). University of Sheffield Press, Sheffield, pp 18?28"},{"key":"CR16","first-page":"6","volume":"28","author":"H Sinzinger","year":"1989","unstructured":"Sinzinger H, Virgolini I, Fitscha P (1989) Pathomechanisms of atherosclerosis beneficially affected by prostaglandin E1 (PGE1)-an update. Vasa [Suppl] 28:6?13","journal-title":"Vasa"},{"key":"CR17","unstructured":"Khan F, Spence VA, Wilson SB, Abbot NC (in press) Quantification of sympathetic vascular responses in skin by laser doppler flowmetry. Int J Microcirc Clin Exp"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2125.1988.tb05276.x","volume":"26","author":"F Khan","year":"1988","unstructured":"Khan F, Struthers AD, Spence VA (1988) The effect of prazosin on skin microcirculation as assessed by laser Doppler flowmetry. Br J Clin Pharmacol 26:267?272","journal-title":"Br J Clin Pharmacol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00332555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00332555\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00332555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T19:23:41Z","timestamp":1554751421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00332555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,11]]},"references-count":18,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[1991,11]]}},"alternative-id":["BF00332555"],"URL":"https:\/\/doi.org\/10.1007\/bf00332555","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,11]]}}}